TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2019

Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer.

Manish A Shah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.